Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.000
-0.080 (-2.60%)
At close: May 30, 2025, 4:00 PM
2.900
-0.100 (-3.33%)
After-hours: May 30, 2025, 7:35 PM EDT
Relay Therapeutics Stock Forecast
RLAY's stock price has decreased by -51.53% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Relay Therapeutics stock ranges from a low of $10 to a high of $24. The average analyst price target of $18.4 forecasts a 513.33% increase in the stock price over the next year.
Price Target: $18.40 (+513.33%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Relay Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $30 → $10 | Strong Buy | Maintains | $30 → $10 | +233.33% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +433.33% | Mar 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +500.00% | Feb 27, 2025 |
| Stifel | Stifel | Strong Buy Maintains $27 → $23 | Strong Buy | Maintains | $27 → $23 | +666.67% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +433.33% | Jan 14, 2025 |
Financial Forecast
Revenue This Year
9.50M
from 10.01M
Decreased by -5.08%
Revenue Next Year
25.57M
from 9.50M
Increased by 169.23%
EPS This Year
-1.93
from -2.36
EPS Next Year
-1.92
from -1.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 31.5M | 81.1M | 112.7M | ||
| Avg | 9.5M | 25.6M | 48.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 214.8% | 753.5% | 340.6% | ||
| Avg | -5.1% | 169.2% | 91.3% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.54 | -1.50 | -1.41 | ||
| Avg | -1.93 | -1.92 | -1.94 | ||
| Low | -2.17 | -2.31 | -2.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.